Towards a vaccine for Cryptococcus neoformans:: principles and caveats

被引:41
作者
Datta, Kausik
Pirofski, Liise-anne
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
关键词
Cryptococcus neoformans; antibody-mediated immunity; vaccine;
D O I
10.1111/j.1567-1364.2006.00073.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the Damage-response framework of microbial pathogenesis, infectious diseases are one outcome of a host-microorganism interaction in a susceptible host. In cryptococcal disease, damage to the host is caused by Cryptococcus neoformans virulence determinants, the nature of the host response, or both. Further, the disease may be acute or reactivated from a latent state. Hence, a vaccine for C. neoformans would need to prevent disease resulting from either acute or reactivated infection. The evidence to support the development of a vaccine for C. neoformans that induces antibody-mediated immunity is discussed herein.
引用
收藏
页码:525 / 536
页数:12
相关论文
共 73 条
[1]   Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of VH3 gene segment usage [J].
Abadi, J ;
Friedman, J ;
Mageed, RA ;
Jefferis, R ;
Rodriguez-Barradas, MC ;
Pirofski, LA .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :707-716
[2]   The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes [J].
Alugupalli, KR ;
Gerstein, RM ;
Chen, JZ ;
Szomolanyi-Tsuda, E ;
Woodland, RT ;
Leong, JM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3819-3827
[3]  
Ashkar Ali A., 2002, Current Molecular Medicine (Hilversum), V2, P545, DOI 10.2174/1566524023362159
[4]  
Banerjee U, 2001, MED MYCOL, V39, P51, DOI 10.1080/mmy.39.1.51.67
[5]   Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8-and diphtheria toxoid-specific antibodies to protection [J].
Batzloff, MR ;
Hayman, WA ;
Davies, MR ;
Zeng, M ;
Pruksakorn, S ;
Brandt, ER ;
Good, MF .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1598-1608
[6]   High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library [J].
Beenhouwer, DO ;
May, RJ ;
Valadon, P ;
Scharff, MD .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6992-6999
[7]   Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans [J].
Beenhouwer, DO ;
Shapiro, S ;
Feldmesser, M ;
Casadevall, A ;
Scharff, MD .
INFECTION AND IMMUNITY, 2001, 69 (10) :6445-6455
[8]   Identification and cloning of a cryptococcal deacetylase that produces protective immune responses [J].
Biondo, C ;
Beninati, C ;
Delfino, D ;
Oggioni, M ;
Mancuso, G ;
Midiri, A ;
Bombaci, M ;
Tomaselli, G ;
Teti, G .
INFECTION AND IMMUNITY, 2002, 70 (05) :2383-2391
[9]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[10]   The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice [J].
Brown, JS ;
Hussell, T ;
Gilliland, SM ;
Holden, DW ;
Paton, JC ;
Ehrenstein, MR ;
Walport, MJ ;
Botto, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) :16969-16974